InvestorsHub Logo
Followers 5
Posts 83
Boards Moderated 0
Alias Born 06/14/2020

Re: None

Monday, 02/01/2021 5:19:56 PM

Monday, February 01, 2021 5:19:56 PM

Post# of 403546
$ipix For new investors:

The Short Mafia has delayed not just one lifesaving drug but two. Brilacidin ...and Kevetrin, IPIX's cancer drug had a successful phase 2 and because of the short attacks, hasn't had the money to put it into phase 3.

https://www.spandidos-publications.com/10.3892/or.2020.7730
"Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells"

leukemia cells and solid tumors..

http://www.ipharminc.com/kevetrin-1

"Innovation has concluded its open-label, dose-escalation Phase 2a trial of Kevetrin in Platinum-Resistant/Refractory Ovarian Cancer. Highly encouraging preliminary data from the first patients treated in the trial showed modulation of the p53 protein in response to administration of Kevetrin.

With a promising bioavailability profile, and to leverage its short half-life (the drug exits the body in approximately 8 to 10 hours), efforts are underway to develop Kevetrin as an oral anti-cancer agent (tablet or capsule) that can be administered daily.."

The Short Mafia have had blood on their hands for years. Covid is just the tip of the iceberg for IPIX.

God bless all
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News